Signature Wealth Management Partners’s GSK GSK Stock Holding History

Signature Wealth Management Partners’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$393K	Hold	7,504	–	–	0.18%	82
2026 Q1	$414K	Hold	7,504	–	–	0.21%	78
2025 Q4	$368K	Hold	7,504	–	–	0.18%	82
2025 Q3	$324K	Hold	7,504	–	–	0.17%	85
2025 Q2	$288K	Hold	7,504	–	–	0.16%	83
2025 Q1	$291K	Hold	7,504	–	–	0.19%	83
2024 Q4	$254K	Hold	7,504	–	–	0.17%	89
2024 Q3	$307K	Hold	7,504	–	–	0.22%	77
2024 Q2	$289K	Hold	7,504	–	–	0.22%	81
2024 Q1	$322K	Hold	7,504	–	–	0.26%	75
2023 Q4	$278K	Sell	7,504 -40	-0.5%	-$1.44K	0.24%	79
2023 Q3	$273K	Buy	7,544 +40	+0.5%	+$1.42K	0.27%	76
2023 Q2	$267K	Hold	7,504	–	–	0.25%	76
2023 Q1	$267K	Hold	7,504	–	–	0.25%	79
2022 Q4	$264K	Hold	7,504	–	–	0.26%	80
2022 Q3	$221K	Sell	7,504 -2	-0%	-$76	0.24%	85
2022 Q2	$408K	Hold	7,506	–	–	0.42%	62
2022 Q1	$409K	Hold	7,506	–	–	0.35%	67
2021 Q4	$414K	Sell	7,506 -1,600	-18%	-$83.2K	0.35%	64
2021 Q3	$435K	Buy	9,106 +1,600	+21%	+$80.4K	0.39%	63
2021 Q2	$374K	Hold	7,506	–	–	0.34%	70
2021 Q1	$335K	Hold	7,506	–	–	0.32%	72
2020 Q4	$345K	Buy	+7,506	New	+$345K	0.34%	64

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Signature Wealth Management Partners's GSK Position: Q2 2026 in Review

Signature Wealth Management Partners held its GSK (GSK) position steady in Q2 2026 at 7,504 shares worth $393K. The position accounts for 0.18% of the portfolio, ranked #82.

Signature Wealth Management Partners first reported a position in GSK in Q4 2020 and has held it in 23 quarters since. The position peaked at $435K in Q3 2021. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Signature Wealth Management Partners held 7,504 shares of GSK worth $393K as of Q2 2026.
Signature Wealth Management Partners left its GSK share count unchanged in Q2 2026.
GSK made up 0.18% of Signature Wealth Management Partners's portfolio in Q2 2026, its #82 holding.
Signature Wealth Management Partners first reported a position in GSK in Q4 2020 and has held it in 23 quarters since.
Signature Wealth Management Partners's GSK position peaked at $435K in Q3 2021.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Signature Wealth Management Partners's 13F filing for Q2 2026, filed 29 Jul 2026.